Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. (Record no. 10186204)

MARC details
000 -LEADER
fixed length control field 01492 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513175717.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199907s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0033-3158
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s002130050925
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Haney, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990702
245 00 - TITLE STATEMENT
Title Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Psychopharmacology
Date of publication, distribution, etc. Mar 1999
300 ## - PHYSICAL DESCRIPTION
Extent 102-10 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Inhalation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cocaine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cocaine-Related Disorders
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dopamine Agonists
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dopamine Uptake Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemodynamics
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prodrugs
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Self Administration
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tetrahydronaphthalenes
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Collins, E D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ward, A S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Foltin, R W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fischman, M W
773 0# - HOST ITEM ENTRY
Title Psychopharmacology
Related parts vol. 143
-- no. 1
-- p. 102-10
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s002130050925">https://doi.org/10.1007/s002130050925</a>
Public note Available from publisher's website

No items available.